Abeona’s skin disease cell therapy launch stymied by false-positive sterility testnews2025-11-13T15:43:19+00:00November 13th, 2025|Endpoints News|
Merck KGaA still in tariff talks with the White House, weeks after deal was announced news2025-11-13T14:29:36+00:00November 13th, 2025|Endpoints News|
WuXi AppTec plants ‘flag down’ in Europe with new Munich headquarters news2025-11-12T17:39:33+00:00November 12th, 2025|Endpoints News|
CDMOs don’t expect immediate impact from ‘most favored nation’ dealsnews2025-11-11T16:04:01+00:00November 11th, 2025|Endpoints News|
Catalent lays off more gene therapy workers in Baltimorenews2025-11-10T14:13:30+00:00November 10th, 2025|Endpoints News|
UPS, Cencora to expand their US operations; Evotec divests biosimilar business to Sandoznews2025-11-06T14:36:04+00:00November 6th, 2025|Endpoints News|
Supernus halts delivery of some Parkinson’s pumps over supply constraintsnews2025-11-05T18:05:08+00:00November 5th, 2025|Endpoints News|
Teva CEO says IRA drug price negotiations met expectationsnews2025-11-05T17:52:56+00:00November 5th, 2025|Endpoints News|
As pharma pour billions in US manufacturing, CDMOs see future opportunitiesnews2025-11-04T13:00:34+00:00November 4th, 2025|Endpoints News|
Lilly earmarks $3B for new European obesity pill factory news2025-11-03T17:58:52+00:00November 3rd, 2025|Endpoints News|
